Alternative Approaches to Targeting the Resistant Phenotype

of Pancreatic Cancer

Jonathan Brody, PhD

Professor, Cell Developmental & Cancer Biology and Surgery;

and Associate Director, Translational Research, Brenden-Colson

Pancreatic Center for Patient Care, Knight Cancer Institute,

Oregon Health & Science University

Zoom –

https://ucsf.zoom.us/j/93782224022?pwd=anpKM0NnSWVYM1lFdVJvcDlOamVLdz09

Password – 230474

Contact – Nancy Presseau – npresseau@mednet.ucla.edu